Shanghai Changzheng Hospital
Clinical trials sponsored by Shanghai Changzheng Hospital, explained in plain language.
-
New oral drug tested alongside standard therapy for advanced prostate cancer
Disease control Not yet recruitingThis early-stage study aims to test the safety and initial effectiveness of an investigational oral drug called LC-K76 when given alongside standard hormone therapy to men with newly diagnosed metastatic prostate cancer. The trial will involve about 40 participants who will take …
Phase: EARLY_PHASE1 • Sponsor: Shanghai Changzheng Hospital • Aim: Disease control
Last updated Apr 03, 2026 14:42 UTC
-
New drug combo tested for Tough-to-Treat prostate cancer
Disease control Not yet recruitingThis early-stage study is testing the safety and initial effectiveness of a new oral drug called LC-K76 when given alongside an immunotherapy drug (Tislelizumab) in men with advanced prostate cancer that has spread to the bones and stopped responding to standard hormone therapies…
Phase: EARLY_PHASE1 • Sponsor: Shanghai Changzheng Hospital • Aim: Disease control
Last updated Apr 03, 2026 14:41 UTC
-
Quantum AI blood test could revolutionize prostate cancer screening
Diagnosis Not yet recruitingThis study is testing a new blood test that uses advanced quantum sensors and artificial intelligence to detect prostate cancer early. It aims to help doctors diagnose cancer more accurately without needing as many invasive biopsies. The test will be studied in about 1,100 men wh…
Sponsor: Shanghai Changzheng Hospital • Aim: Diagnosis
Last updated Mar 18, 2026 14:41 UTC